Treatment of osseous metastases using the Spinal Tumor Ablation with Radiofrequency (STAR) system

References

• Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31(5):578–583.
   PubMed Web of Science ®Google Scholar
• Lee YT. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol. 1983;23(3):175–180.
   PubMed Web of Science ®Google Scholar
• Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–6249s.
   PubMed Web of Science ®Google Scholar
• Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2(8):584–593.
   PubMed Web of Science ®Google Scholar
• Suva LJ, Washam C, Nicholas RW, et al. Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol. 2011;7(4):208–218.
   PubMed Web of Science ®Google Scholar
• Witham TF, Khavkin YA, Gallia GL, et al. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol. 2006;2(2): 87-94; quiz 116.
   PubMedGoogle Scholar
• Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8(2):98–101.
   PubMed Web of Science ®Google Scholar
• Jones DH, Nakashima T, Sanchez OH, et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature. 2006;440(7084):692–696.
   PubMed Web of Science ®Google Scholar
• Russell HV, Hicks J, Okcu MF, et al. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. J Pediatr Surg. 2004;39(10):1506–1511.
   PubMed Web of Science ®Google Scholar
• Yin JJ, Pollock CB, Kelly K. Mechanisms of cancer metastasis to the bone. Cell Res. 2005;15(1):57–62.
   PubMed Web of Science ®Google Scholar
• Yin JJ, Selander K, Chirgwin JM, et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest. 1999;103(2):197–206.
   PubMed Web of Science ®Google Scholar
• Theriault RL, Theriault RL. Biology of bone metastases. Cancer Control. 2012;19(2):92–101.
   PubMed Web of Science ®Google Scholar
• Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg. 1940;112(1):138–149.
   PubMedGoogle Scholar
• Wallace AN, Greenwood TJ, Jennings JW. Use of imaging in the management of metastatic spine disease with percutaneous ablation and vertebral augmentation. AJR Am J Roentgenol. 2015;205(2):434–441.
   PubMed Web of Science ®Google Scholar
• Urch C. The pathophysiology of cancer-induced bone pain: current understanding. Palliat Med. 2004;18(4):267–274.
   PubMed Web of Science ®Google Scholar
• Middlemiss T, Laird BJ, Fallon MT. Mechanisms of cancer-induced bone pain. Clin Oncol (R Coll Radiol). 2011;23(6):387–392.
   PubMed Web of Science ®Google Scholar
• Grill V, Ho P, Body JJ, et al. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab. 1991;73(6):1309–1315.
   PubMed Web of Science ®Google Scholar
• Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the spine oncology study group. Spine (Phila Pa 1976). 2010;35(22):E1221-9.
   PubMed Web of Science ®Google Scholar
• Hill ME, Richards MA, Gregory WM, et al. Spinal cord compression in breast cancer: a review of 70 cases. Br J Cancer. 1993;68(5):969–973.
   PubMed Web of Science ®Google Scholar
• Wallace AN, Robinson CG, Meyer J, et al. The metastatic spine disease multidisciplinary working group algorithms. Oncologist. 2015;20(10):1205–1215.
   PubMed Web of Science ®Google Scholar
• Yu HH, Tsai YY, Hoffe SE. Overview of diagnosis and management of metastatic disease to bone. Cancer Control. 2012;19(2):84–91.
   PubMed Web of Science ®Google Scholar
• Stopeck AT, Lipton A, Body -J-J, et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol. 2010;28(35):5132–5139.
   PubMed Web of Science ®Google Scholar
• Wong MH, Stockler MR, Pavlakis N. Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev. 2012;2:CD003474.
   Google Scholar
• Kim JM, Losina E, Bono CM, et al. Clinical outcome of metastatic spinal cord compression treated with surgical excision ± radiation versus radiation therapy alone: a systematic review of literature. Spine (Phila Pa 1976). 2012;37(1):78–84.
   PubMed Web of Science ®Google Scholar
• Gerszten PC. Spine metastases: from radiotherapy, surgery, to radiosurgery. Neurosurgery. 2014;61(Suppl 1):16–25.
   PubMedGoogle Scholar
• Wood TJ, Racano A, Yeung H, et al. Surgical management of bone metastases: quality of evidence and systematic review. Ann Surg Oncol. 2014;21(13):4081–4089.
   PubMed Web of Science ®Google Scholar
• Haentjens P, Casteleyn PP, Opdecam P. Evaluation of impending fractures and indications for prophylactic fixation of metastases in long bones. Review of the literature. Acta Orthop Belg. 1993;59(Suppl 1):6–11.
   PubMedGoogle Scholar
• Townsend PW, Rosenthal HG, Smalley SR, et al. Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol. 1994;12(11):2345–2350.
   PubMed Web of Science ®Google Scholar
• Townsend PW, Smalley SR, Cozad SC, et al. Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys. 1995;31(1):43–49.
   PubMed Web of Science ®Google Scholar
• Castaneda Rodriguez WR, Callstrom MR. Effective pain palliation and prevention of fracture for axial-loading skeletal metastases using combined cryoablation and cementoplasty. Tech Vasc Interv Radiol. 2011;14(3):160–169.
   PubMedGoogle Scholar
• Berenson J, Pflugmacher R, Jarzem P, et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol. 2011;12(3):225–235.
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643–648.
   PubMed Web of Science ®Google Scholar
• Gangi A, Buy X. Percutaneous bone tumor management. Semin Intervent Radiol. 2010;27(2):124–136.
   PubMedGoogle Scholar
• Kurup AN, Callstrom MR. Image-guided percutaneous ablation of bone and soft tissue tumors. Semin Intervent Radiol. 2010;27(3):276–284.
   PubMedGoogle Scholar
• Wallace AN, Huang AJ, Vaswani D, et al. Combination acetabular radiofrequency ablation and cementoplasty using a navigational radiofrequency ablation device and ultrahigh viscosity cement: technical note. Skeletal Radiol. 2016;45(3):401–405.
   PubMed Web of Science ®Google Scholar
• Lane MD, Le HBQ, Lee S, et al. Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patients. Skeletal Radiol. 2011;40(1):25–32.
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330(9):592–596.
   PubMed Web of Science ®Google Scholar
• Wallace AN, Greenwood TJ, Jennings JW. Radiofrequency ablation and vertebral augmentation for palliation of painful spinal metastases. J Neurooncol. 2015;124(1):111–118.
   PubMed Web of Science ®Google Scholar
• Heran MK, Legiehn GM, Munk PL. Current concepts and techniques in percutaneous vertebroplasty. Orthop Clin North Am. 2006;37(3): 409–34, vii.
   PubMed Web of Science ®Google Scholar
• Weill A, Chiras J, Simon JM, et al. Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology. 1996;199(1):241–247.
   PubMed Web of Science ®Google Scholar
• Anchala PR, Irving WD, Hillen TJ, et al. Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device: a multicenter retrospective study. Pain Physician. 2014;17(4):317–327.
   PubMed Web of Science ®Google Scholar
• Hillen TJ, Anchala P, Friedman MV, et al. Treatment of metastatic posterior vertebral body osseous tumors by using a targeted bipolar radiofrequency ablation device: technical note. Radiology. 2014;273(1):261–267.
   PubMed Web of Science ®Google Scholar
• Lo SS, Sahgal A, Hartsell WF, et al. The treatment of bone metastasis with highly conformal radiation therapy: a brave new world or a costly mistake? Clin Oncol (R Coll Radiol). 2009;21(9):662–664.
   PubMed Web of Science ®Google Scholar
• Valesin Filho ES, De Abreu LC, Lima GH, et al. Pain and quality of life in patients undergoing radiotherapy for spinal metastatic disease treatment. Int Arch Med. 2013;6(1):6.
   PubMedGoogle Scholar
• Agarawal JP, Swangsilpa T, van der Linden Y, et al. The role of external beam radiotherapy in the management of bone metastases. Clin Oncol (R Coll Radiol). 2006;18(10):747–760.
   PubMed Web of Science ®Google Scholar
• Masucci GL, Yu E, Ma L, et al. Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practice. Expert Rev Anticancer Ther. 2011;11(12):1923–1933.
   PubMed Web of Science ®Google Scholar
• Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22(2):300–306.
   PubMed Web of Science ®Google Scholar
• Dupuy DE, Liu D, Hartfeil D, et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter american college of radiology imaging network trial. Cancer. 2010;116(4):989–997.
   PubMed Web of Science ®Google Scholar
• Wallace AN, Tomasian A, Vaswani D, et al. Radiographic local control of spinal metastases with percutaneous radiofrequency ablation and vertebral augmentation. AJNR Am J Neuroradiol. 2016;37(4):759–765.
   PubMed Web of Science ®Google Scholar
• Singh D, Yi WS, Brasacchio RA, et al. Is there a favorable subset of patients with prostate cancer who develop oligometastases? Int J Radiat Oncol Biol Phys. 2004;58(1):3–10.
   PubMed Web of Science ®Google Scholar
• Tsoumakidou G, Koch G, Caudrelier J, et al. Image-guided spinal ablation: a review. Cardiovasc Intervent Radiol. 2016;39(9):1229–1238.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Brace CL, Lee FT, et al. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–369.
   PubMed Web of Science ®Google Scholar
• Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 2009;58(1):1–11.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
   PubMed Web of Science ®Google Scholar
• Prologo JD, Passalacqua M, Patel I, et al. Image-guided cryoablation for the treatment of painful musculoskeletal metastatic disease: a single-center experience. Skeletal Radiol. 2014;43(11):1551–1559.
   PubMed Web of Science ®Google Scholar
• Thacker PG, Callstrom MR, Curry TB, et al. Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients’ immediate response to radiofrequency ablation and cryoablation. AJR Am J Roentgenol. 2011;197(2):510–515.
   PubMed Web of Science ®Google Scholar
• Callstrom MR, Kurup AN. Percutaneous ablation for bone and soft tissue metastases–why cryoablation? Skeletal Radiol. 2009;38(9):835–839.
   PubMed Web of Science ®Google Scholar
• McMenomy BP, Kurup AN, Johnson GB, et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol. 2013;24(2):207–213.
   PubMed Web of Science ®Google Scholar
• Tomasian A, Wallace A, Northrup B, et al. Spine cryoablation: pain palliation and local tumor control for vertebral metastases. AJNR Am J Neuroradiol. 2016;37(1):189–195.
   PubMed Web of Science ®Google Scholar
• Kastler A, Alnassan H, Aubry S, et al. Microwave thermal ablation of spinal metastatic bone tumors. J Vasc Interv Radiol. 2014;25(9):1470–1475.
   PubMed Web of Science ®Google Scholar
• Pusceddu C, Sotgia B, Fele RM, et al. Treatment of bone metastases with microwave thermal ablation. J Vasc Interv Radiol. 2013;24(2):229–233.
   PubMed Web of Science ®Google Scholar
• Wallace AN, Tomasian A, Chang RO, et al. Treatment of osteoid osteomas using a navigational bipolar radiofrequency ablation system. Cardiovasc Intervent Radiol. 2016;39(5):768–772.
   PubMed Web of Science ®Google Scholar
• Huffman SD, Huffman NP, Lewandowski RJ, et al. Radiofrequency ablation complicated by skin burn. Semin Intervent Radiol. 2011;28(2):179–182.
   PubMedGoogle Scholar
• Madaelil TP, Wallace AN, Jennings JW. Radiofrequency ablation alone or in combination with cementoplasty for local control and pain palliation of sacral metastases: preliminary results in 11 patients. Skeletal Radiol. 2016;45(9):1213–1219.
   PubMed Web of Science ®Google Scholar
• Thanos L, Mylona S, Galani P, et al. Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol. 2008;37(3):189–194.
   PubMed Web of Science ®Google Scholar
• Bagla S, Sayed D, Smirniotopoulos J, et al. Multicenter prospective clinical series evaluating radiofrequency ablation in the treatment of painful spine metastases. Cardiovasc Intervent Radiol. 2016;39(9):1289–1297.
   PubMed Web of Science ®Google Scholar
• Miles WK, Chang DW, Kroll SS, et al. Reconstruction of large sacral defects following total sacrectomy. Plast Reconstr Surg. 2000;105(7):2387–2394.
   PubMed Web of Science ®Google Scholar
• Dolan RT, Butler JS, Wilson-MacDonald J, et al. Quality of life and surgical outcomes after soft-tissue reconstruction of complex oncologic defects of the spine and sacrum. J Bone Joint Surg Am. 2016;98(2):117–126.
   PubMed Web of Science ®Google Scholar
• Hellevik T, Martinez-Zubiaurre I. Radiotherapy and the tumor stroma: the importance of dose and fractionation. Front Oncol. 2014;4:1.
   PubMedGoogle Scholar
• Di Staso M, Zugaro L, Gravina GL, et al. A feasibility study of percutaneous radiofrequency ablation followed by radiotherapy in the management of painful osteolytic bone metastases. Eur Radiol. 2011;21(9):2004–2010.
   PubMed Web of Science ®Google Scholar
• Greenwood TJ, Wallace A, Friedman MV, et al. Combined ablation and radiation therapy of spinal metastases: a novel multimodality treatment approach. Pain Physician. 2015;18(6):573–581.
   PubMed Web of Science ®Google Scholar
• Haen SP, Pereira PL, Salih HR, et al. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol. 2011;2011:160250.
   PubMed Web of Science ®Google Scholar
• Rozenblum N, Zeira E, Scaiewicz V, et al. Oncogenesis: an “off-target” effect of radiofrequency ablation. Radiology. 2015;276(2):426–432.
   PubMed Web of Science ®Google Scholar
• Nijkamp MW, van der Bilt JDW, de Bruijn MT, et al. Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Ann Surg. 2009;249(5):814–823.
   PubMed Web of Science ®Google Scholar
• Poon RT, Lau C, Pang R, et al. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies. Ann Surg Oncol. 2007;14(6):1835–1845.
   PubMed Web of Science ®Google Scholar
• Ahmad F, Gravante G, Bhardwaj N, et al. Changes in interleukin-1beta and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections. Am J Surg. 2010;200(4):500–506.
   PubMed Web of Science ®Google Scholar
• Erinjeri JP, Thomas CT, Samoilia A, et al. Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. J Vasc Interv Radiol. 2013;24(8):1105–1112.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Kumar G, Moussa M, et al. Hepatic radiofrequency ablation-induced stimulation of distant tumor growth is suppressed by c-met inhibition. Radiology. 2016;279(1):103–117.
   PubMed Web of Science ®Google Scholar
• Chapiro J, Geschwind JF. Science to practice: the changing face of local tumor therapies-do we have to think systemically when treating cancer locally? Radiology. 2015;276(2):315–317.
   PubMed Web of Science ®Google Scholar
• Mehta A, Oklu R, Sheth RA. Thermal ablative therapies and immune checkpoint modulation: can locoregional approaches effect a systemic response? Gastroenterol Res Pract. 2016;2016:9251375.
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Mizukoshi E, Iida N, et al. In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation. Cancer Immunol Immunother. 2014;63(4):347–356.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhai B, Yang W, et al. Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine. Mol Ther. 2009;17(12):2049–2057.
   PubMed Web of Science ®Google Scholar
• Cui J, Wang N, Zhao H, et al. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma. Int J Cancer. 2014;134(2):342–351.
   PubMed Web of Science ®Google Scholar
• Chen Z, Shen S, Peng B, et al. Intratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antitumour immunity induced by thermal ablation in a subcutaneous murine hepatoma model. Int J Hyperthermia. 2009;25(5):374–382.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Kumar G, Navarro G, et al. Systemic siRNA nanoparticle-based drugs combined with radiofrequency ablation for cancer therapy. PLoS One. 2015;10(7):e0128910.
   Web of Science ®Google Scholar
• Moussa M, Goldberg SN, Kumar G, et al. Radiofrequency ablation-induced upregulation of hypoxia-inducible factor-1alpha can be suppressed with adjuvant bortezomib or liposomal chemotherapy. J Vasc Interv Radiol. 2014;25(12):1972–1982.
   PubMed Web of Science ®Google Scholar